Search hospitals > California > La Mesa
Horizon Clinical Research
Claim this profileLa Mesa, California 91942
Global Leader in Osteoarthritis
Conducts research for Osteoarthritis Treatment Costs
Conducts research for Knee Arthritis
Conducts research for Chronic Knee Pain
Conducts research for Chondromalacia Patellae
12 reported clinical trials
1 medical researcher
Summary
Horizon Clinical Research is a medical facility located in La Mesa, California. This center is recognized for care of Osteoarthritis, Osteoarthritis Treatment Costs, Knee Arthritis, Chronic Knee Pain, Chondromalacia Patellae and other specialties. Horizon Clinical Research is involved with conducting 12 clinical trials across 19 conditions. There are 1 research doctors associated with this hospital, such as Scott Hacker, MD.Top PIs
Clinical Trials running at Horizon Clinical Research
Osteoarthritis Treatment Costs
Cartilage Damage
Cartilage Injury
Shoulder Arthritis
Osteoarthritis
Knee Arthritis
ZILRETTA
for Shoulder Osteoarthritis
Primary Objective: To assess the efficacy of ZILRETTA on pain following an intra-articular (IA) injection in subjects with glenohumeral osteoarthritis (OA) relative to normal saline placebo Secondary Objective: * To assess the efficacy of ZILRETTA on pain following an IA injection in subjects with glenohumeral OA relative to triamcinolone acetonide injectable suspension, immediate release (TCA-IR) and normal saline placebo * To assess the safety of ZILRETTA in subjects with glenohumeral OA relative to normal saline placebo and TCA-IR
Recruiting1 award Phase 3
Enekinragene Inzadenovec
for Knee Arthritis
The goal of this clinical trial is to learn if a single knee injection of different doses (Dose A and Dose B) of an investigation product PCRX-201, following steroid pretreatment, is safe and tolerable in male of female patients 45 to 80 years old with osteoarthritis of the knee. It will also learn how the body reacts to the PCRX-201 injection and how effective the treatment is. Researchers will compare Dose A and Dose B of PCRX-201 versus placebo from Week 1 through Week 52 to assess adverse events. Researchers will also explore how PCRX-201 may impact knee pain and joint function over time. Participants will be asked to * Visit the clinic for pretreatment and drug administration * Visit the clinic for checkups and tests: 1. Screening through Week 52: intially weekly, bi-weekly, later monthly 2. Week 53 through Week 260 (Year 5): 8 visits throughout the period
Recruiting0 awards Phase 28 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Horizon Clinical Research?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.